These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21350792)

  • 21. Comparison of the vasoconstrictor effects of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) and zolmitriptan in human isolated coronary arteries.
    Lynch JJ; Regan CP; Edvinsson L; Hargreaves RJ; Kane SA
    J Cardiovasc Pharmacol; 2010 May; 55(5):518-21. PubMed ID: 20164785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and preclinical rationale for CGRP-receptor antagonists in the treatment of migraine.
    Tepper SJ; Stillman MJ
    Headache; 2008 Sep; 48(8):1259-68. PubMed ID: 18808506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized, controlled study of telcagepant in patients with migraine and coronary artery disease.
    Ho TW; Ho AP; Chaitman BR; Johnson C; Mathew NT; Kost J; Fan X; Aurora SK; Brandes JL; Fei K; Beebe L; Lines C; Krucoff MW
    Headache; 2012 Feb; 52(2):224-35. PubMed ID: 22221076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Twenty-five years of triptans - a nationwide population study.
    Davidsson OB; Olofsson IA; Kogelman LJ; Andersen MA; Rostgaard K; Hjalgrim H; Olesen J; Hansen TF
    Cephalalgia; 2021 Jul; 41(8):894-904. PubMed ID: 33583217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative aspects of triptans in treating migraine.
    Adelman JU; Lewit EJ
    Clin Cornerstone; 2001; 4(3):53-64. PubMed ID: 12739316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis.
    Cameron C; Kelly S; Hsieh SC; Murphy M; Chen L; Kotb A; Peterson J; Coyle D; Skidmore B; Gomes T; Clifford T; Wells G
    Headache; 2015; 55 Suppl 4():221-35. PubMed ID: 26178694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-Effectiveness of Reclassifying Triptans in Australia: Application of an Economic Evaluation Approach to Regulatory Decisions.
    Parkinson B; Gumbie M; Cutler H; Gauld N; Mumford V; Haywood P
    Value Health; 2019 Mar; 22(3):293-302. PubMed ID: 30832967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized, controlled trial of telcagepant for the acute treatment of migraine.
    Connor KM; Shapiro RE; Diener HC; Lucas S; Kost J; Fan X; Fei K; Assaid C; Lines C; Ho TW
    Neurology; 2009 Sep; 73(12):970-7. PubMed ID: 19770473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New drugs in migraine treatment and prophylaxis: telcagepant and topiramate.
    Edvinsson L; Linde M
    Lancet; 2010 Aug; 376(9741):645-55. PubMed ID: 20416945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.
    Ferrari MD; Roon KI; Lipton RB; Goadsby PJ
    Lancet; 2001 Nov; 358(9294):1668-75. PubMed ID: 11728541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of triptans for pediatric migraines.
    Eiland LS; Hunt MO
    Paediatr Drugs; 2010 Dec; 12(6):379-89. PubMed ID: 21028917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of triptans for migraine headaches during pregnancy and breastfeeding.
    Duong S; Bozzo P; Nordeng H; Einarson A
    Can Fam Physician; 2010 Jun; 56(6):537-9. PubMed ID: 20547518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Migraine: Telcagepant provides new hope for people with migraine.
    Edvinsson L
    Nat Rev Neurol; 2009 May; 5(5):240-2. PubMed ID: 19488079
    [No Abstract]   [Full Text] [Related]  

  • 34. Theory-based analysis of clinical efficacy of triptans using receptor occupancy.
    Tokuoka K; Takayanagi R; Suzuki Y; Watanabe M; Kitagawa Y; Yamada Y
    J Headache Pain; 2014 Dec; 15(1):85. PubMed ID: 25488888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Almotriptan: a review of its use in migraine.
    Keam SJ; Goa KL; Figgitt DP
    Drugs; 2002; 62(2):387-414. PubMed ID: 11817980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of acute and chronic migraine.
    Coppola G; Schoenen J
    Curr Opin Support Palliat Care; 2012 Jun; 6(2):177-82. PubMed ID: 22406987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spotlight on almotriptan in migraine.
    Keam SJ; Goa KL; Figgitt DP
    CNS Drugs; 2002; 16(7):501-7. PubMed ID: 12056924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frovatriptan: a review of its use in the acute treatment of migraine.
    Sanford M
    CNS Drugs; 2012 Sep; 26(9):791-811. PubMed ID: 22900951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecule of the month. Telcagepant.
    Drug News Perspect; 2009 Mar; 22(2):115. PubMed ID: 19330169
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysis.
    Thorlund K; Mills EJ; Wu P; Ramos E; Chatterjee A; Druyts E; Goadsby PJ
    Cephalalgia; 2014 Apr; 34(4):258-67. PubMed ID: 24108308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.